-
Product Insights
New![]()
Net Present Value Model: Dare Bioscience Inc’s Sildenafil citrate
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Profile
![]()
Dare Bioscience Inc – Company Profile
Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. It offers products that include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use, and topical 5% sildenafil citrate cream for women with female sexual arousal...
Add to Basket -
Product Insights
Dare County – Kill Devil Hills Fire and EMS Station Development – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Dare County - Kill Devil Hills Fire and EMS Station Development - North Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Diclofenac in Primary Dysmenorrhea
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Diclofenac in Primary DysmenorrheaDrug Details:Diclofenac (DARE-PDM1) is under development for the treatment of primary dysmenorrhea. The...
-
Product Insights
New![]()
Net Present Value Model: NGM Biopharmaceuticals Inc’s NGM-120
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Thematic Analysis
New![]()
Aerospace, Defense and Security Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q2 2023 in the Aerospace, Defense and Security Sector
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SHR-1707 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SHR-1707 in Alzheimer's Disease Drug Details:SHR-1707 is under development for the treatment of Alzheimer’s disease. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sildenafil Citrate in Female Hypoactive Sexual Desire Disorder
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. Sildenafil Citrate in Female Hypoactive Sexual Desire Disorder Drug Details: Sildenafil citrate (SST-6007) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Estradiol + Progesterone) in Genitourinary Syndrome of Menopause (GSM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Estradiol + Progesterone) in Genitourinary Syndrome of Menopause (GSM)Drug Details:Estradiol in combination with progesterone is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Estradiol + Progesterone) in Vasomotor Symptoms of Menopause (Hot Flashes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Estradiol + Progesterone) in Vasomotor Symptoms of Menopause (Hot Flashes) Drug Details:Estradiol in combination with progesterone...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XKDCT-023 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XKDCT-023 in Solid Tumor Drug Details:XKDCT023 is under development for the treatment of CD19 positive recurrent...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Omacetaxine Mepesuccinate in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Omacetaxine Mepesuccinate in Relapsed Acute Myeloid Leukemia Drug Details:Omacetaxine mepesuccinate (Homoharringtonine, Omapro, Synribo, Tekinex, CGX635) is an...
-
Company Profile
![]()
Olvi plc – Company Profile
Olvi plc (Olvi) manufactures, distributes, and markets alcoholic and non-alcoholic beverages. The company's product portfolio includes beers, ciders, whiskey, wine, gin, long drinks, energy drinks, soft drinks, juices, sports beverages, syrups, kvass, mineral water and other alcoholic and non alcoholic beverages. Olvi sells its products under the brands of OLVI, A. Le Coq, Muteman, Daring Daughter, A. Le Coq Fassbrause, Sandels, Motor Oil, Sherwood, Olvi Vichy, FIZZ, KevytOlo, Kane's Soda Pop and TEHO, among others. It also provides service of...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Romosozumab in Osteogenesis Imperfecta
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Romosozumab in Osteogenesis ImperfectaDrug Details: Romosozumab (Evenity) is a humanized monoclonal antibody. It is formulated as...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RP-3 in Gastrointestinal Tract Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RP-3 in Gastrointestinal Tract Cancer Drug Details: RP-3 is under development for the treatment of ...
-
Track & Monitor
New![]()
Innovation in medical: Ingestible sensors
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the medical industry’s Ingestible sensors innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience in...
-
Product Insights
Dare Bioscience Inc Pipeline Insight and Competitive Landscape, 2023
Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. It offers products that include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use; and topical 5% sildenafil citrate cream for women with female sexual arousal...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...
-
Product Insights
Dare Propert/ Fortis Dev Group – Piper House Residential Development – New South Wales
Dare Propert/ Fortis Dev Group – Piper House Residential Development – New South Wales involves the construction of a four-story residential tower with 15 luxury apartments on 0.26ha of land in Sydney, New South Wales, Australia. The US$104 million (AUD150 million) project includes the following: 1. Construction of basement car parking 2. Construction of a spa 3. Construction of restaurants 4. ..... more details on the scope of this project are covered in the report. In addition, the project profile...
-
Product Insights
Dares Datca
Dares Datca is a 41.6MW onshore wind power project located in Mugla, Turkey. It was developed by Dares Datca Ruzgar Enerji Santrali Sanayi ve Ticaret A.S.. The project is currently active. The project started its commercial operations in 2008. The project is owned by Dares Datca Ruzgar Enerji Santrali Sanayi ve Ticaret A.S.. Dares Datca profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.